Cryo Cell International (CCEL) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $3.65, -12.05% vs the prior close of $4.15.
- Volume 16.70K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CCEL slides 12.0% to $3.65, 3 down days in a row. Closed at $3.65, -12.05% vs the prior close of $4.15. Day range $3.65–$4.46, opened at $4.05.
CCEL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CCEL slides 12.0% to $3.65, 3 down days in a row
- Closed at $3.65, -12.05% vs the prior close of $4.15. Day range $3.65–$4.46, opened at $4.05.
- Volume was 16.70K shares, 0.6x its 50-day average of 28.74K — lighter than usual.
- Price is -10.6% vs its 50-day average ($4.08) and +1.2% vs its 200-day average ($3.61).
- 52-week range $2.72–$4.90; today's close sits at 43% of that range, 25.5% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — CCEL slides 3.5% to $4.15
- Closed at $4.15, -3.49% vs the prior close of $4.30. Day range $4.14–$4.38, opened at $4.38.
- Volume was 9.60K shares, 0.3x its 50-day average of 28.77K — lighter than usual.
- Price is +1.6% vs its 50-day average ($4.08) and +15.1% vs its 200-day average ($3.61).
- 52-week range $2.72–$4.90; today's close sits at 66% of that range, 15.3% below the 52-week high.
Oct 13, 2026 — CCEL slides 4.4% to $4.30
- Closed at $4.30, -4.44% vs the prior close of $4.50. Day range $4.15–$4.52, opened at $4.15.
- Volume was 15.20K shares, 0.5x its 50-day average of 28.60K — lighter than usual.
- Price is +5.6% vs its 50-day average ($4.07) and +19.4% vs its 200-day average ($3.60).
- 52-week range $2.72–$4.90; today's close sits at 72% of that range, 12.2% below the 52-week high.
- SEC filings that day: DEF 14A.
Oct 12, 2026 — CCEL jumps 3.2% to $4.50, a 1-month high, 5 up days in a row
- Closed at $4.50, +3.21% vs the prior close of $4.36. Day range $4.48–$4.89, opened at $4.75.
- Volume was 43.80K shares, 1.6x its 50-day average of 27.87K.
- Price is +10.9% vs its 50-day average ($4.06) and +25.1% vs its 200-day average ($3.60).
- 52-week range $2.72–$4.90; today's close sits at 82% of that range, 8.2% below the 52-week high.
- That makes 5 straight gains.
Oct 9, 2026 — CCEL jumps 4.6% to $4.36, 4 up days in a row
- Closed at $4.36, +4.56% vs the prior close of $4.17. Day range $4.00–$4.47, opened at $4.00.
- Volume was 5.50K shares, 0.2x its 50-day average of 28.18K — lighter than usual.
- Price is +8.1% vs its 50-day average ($4.03) and +21.3% vs its 200-day average ($3.59).
- 52-week range $2.72–$4.90; today's close sits at 75% of that range, 11.0% below the 52-week high.
- That makes 4 straight gains.
- SEC filings that day: 10-Q.
Oct 8, 2026 — CCEL jumps 6.6% to $4.17 on 1.8x normal volume
- Closed at $4.17, +6.65% vs the prior close of $3.91. Day range $3.70–$4.72, opened at $4.04.
- Volume was 50.40K shares, 1.8x its 50-day average of 27.46K — unusually heavy trading.
- Price is +3.9% vs its 50-day average ($4.01) and +16.2% vs its 200-day average ($3.59).
- 52-week range $2.72–$4.90; today's close sits at 67% of that range, 14.9% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 — CCEL rises 0.8% to $3.91
- Closed at $3.91, +0.77% vs the prior close of $3.88. Day range $3.90–$3.93, opened at $3.90.
- Volume was 4.00K shares, 0.1x its 50-day average of 27.48K — lighter than usual.
- Price is -2.2% vs its 50-day average ($4.00) and +9.0% vs its 200-day average ($3.59).
- 52-week range $2.72–$4.90; today's close sits at 55% of that range, 20.2% below the 52-week high.
Oct 6, 2026 — CCEL jumps 4.6% to $3.88
- Closed at $3.88, +4.58% vs the prior close of $3.71. Day range $3.42–$4.00, opened at $4.00.
- Volume was 17.00K shares, 0.6x its 50-day average of 27.28K.
- Price is -2.7% vs its 50-day average ($3.99) and +8.2% vs its 200-day average ($3.59).
- 52-week range $2.72–$4.90; today's close sits at 53% of that range, 20.8% below the 52-week high.
Oct 5, 2026 — CCEL slides 7.0% to $3.71, 3 down days in a row
- Closed at $3.71, -7.02% vs the prior close of $3.99. Day range $3.71–$4.05, opened at $4.02.
- Volume was 13.10K shares, 0.5x its 50-day average of 27.07K — lighter than usual.
- Price is -6.7% vs its 50-day average ($3.98) and +3.5% vs its 200-day average ($3.59).
- 52-week range $2.72–$4.90; today's close sits at 45% of that range, 24.3% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — CCEL dips 1.5% to $3.99
- Closed at $3.99, -1.48% vs the prior close of $4.05. Day range $3.99–$4.11, opened at $4.11.
- Volume was 1.50K shares, 0.1x its 50-day average of 27.11K — lighter than usual.
- Price is +0.5% vs its 50-day average ($3.97) and +11.3% vs its 200-day average ($3.59).
- 52-week range $2.72–$4.90; today's close sits at 58% of that range, 18.6% below the 52-week high.
CCEL latest news & SEC filings
Every SEC filing by or about CCEL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Oct 13, 2026 · ARS — Annual report to shareholders
Annual report to shareholders
Oct 9, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Aug 31, 2026:
- Net income: $1.27M (prior year $749.41K) (+69.5% vs Aug 31, 2025)
- Diluted EPS: $0.16 (prior year $0.09) (+77.8% vs Aug 31, 2025)
Sep 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 7, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 15, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended May 31, 2026:
- Net income: $554.59K (prior year $355.79K) (+55.9% vs May 31, 2025)
- Diluted EPS: $0.07 (prior year $0.04) (+75.0% vs May 31, 2025)
Jul 7, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade CCEL
- Last results release: Oct 17, 2024 (8-K Item 2.02). Previous ones: Feb 24, 2022, Oct 15, 2021, Jul 19, 2021. Based on that rhythm, the next report is likely around Jan 16, 2025 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.58% (largest 19.8%). That is a volatile stock.
- Liquidity: about 13.48K shares (≈$49.22K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.65 vs a range of $2.72–$4.90 (43% of the range).
- Dividends: last ex-dividend date May 21, 2025 ($0.15/share); 0 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Oct 9, 2026; 8-K Sep 14, 2026; 10-Q Jul 15, 2026.
- Share count: 8.06M shares outstanding (Oct 8, 2026), +0.1% vs a year earlier.
- Listing: NYSE · industry: Services-Misc Health & Allied Services, NEC.
CCEL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 4.05 | 4.46 | 3.65 | 3.65 | 16.70K |
| Oct 14, 2026 | 4.38 | 4.38 | 4.14 | 4.15 | 9.60K |
| Oct 13, 2026 | 4.15 | 4.52 | 4.15 | 4.30 | 15.20K |
| Oct 12, 2026 | 4.75 | 4.89 | 4.48 | 4.50 | 43.80K |
| Oct 9, 2026 | 4.00 | 4.47 | 4.00 | 4.36 | 5.50K |
| Oct 8, 2026 | 4.04 | 4.72 | 3.70 | 4.17 | 50.40K |
| Oct 7, 2026 | 3.90 | 3.93 | 3.90 | 3.91 | 4.00K |
| Oct 6, 2026 | 4.00 | 4.00 | 3.42 | 3.88 | 17.00K |
| Oct 5, 2026 | 4.02 | 4.05 | 3.71 | 3.71 | 13.10K |
| Oct 2, 2026 | 4.11 | 4.11 | 3.99 | 3.99 | 1.50K |
| Oct 1, 2026 | 3.99 | 4.14 | 3.96 | 4.05 | 27.80K |
| Sep 30, 2026 | 4.20 | 4.20 | 4.15 | 4.20 | 2.20K |
| Sep 29, 2026 | 4.05 | 4.05 | 4.05 | 4.05 | 500 |
| Sep 28, 2026 | 4.16 | 4.16 | 4.15 | 4.16 | 1.90K |
| Sep 25, 2026 | 4.24 | 4.24 | 4.24 | 4.24 | 300 |
| Sep 24, 2026 | 3.99 | 4.14 | 3.81 | 4.03 | 6.80K |
| Sep 23, 2026 | 4.01 | 4.05 | 3.99 | 3.99 | 1.10K |
| Sep 22, 2026 | 3.63 | 4.61 | 3.63 | 4.16 | 30.20K |
| Sep 21, 2026 | 4.32 | 4.32 | 3.49 | 3.53 | 11.10K |
| Sep 18, 2026 | 4.17 | 4.40 | 4.00 | 4.40 | 11.00K |
About Cryo Cell International
Cryo Cell International (CCEL) is listed on the NYSE and classified by the SEC under “Services-Misc Health & Allied Services, NEC”. Its business address is in OLDSMAR, FL. State of incorporation: DE. Fiscal year ends November 30. SEC CIK 862692.
CCEL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Harold D. Berger | Director | Oct 23, 2025 |
| Daniel Mizrahi | Director | Oct 23, 2025 |
| David Portnoy | Chairman, Co-CEO | Aug 7, 2026 |
| Mark L. Portnoy | Co-CEO | Jan 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Oleg Mikulinsky | Chief Information Officer | Jan 9, 2026 |
| David Portnoy | Chairman, Co-CEO | Aug 7, 2026 |
| Mark L. Portnoy | Co-CEO | Jan 9, 2026 |
| Jill M Taymans | VP Finance, CFO | May 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CCEL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Nov 30, 2025 | — | $-2.43M | -0.30 | $5.48M |
| Nov 30, 2024 | — | $402.10K | 0.05 | $6.01M |
| Nov 30, 2023 | — | $-9.52M | -1.14 | $8.92M |
| Nov 30, 2022 | — | $2.77M | 0.33 | $8.57M |
| Nov 30, 2021 | — | $2.08M | 0.25 | $7.93M |
Latest balance sheet: total assets $62.30M, total liabilities $78.70M, cash $1.43M (as of Aug 31, 2026).
CCEL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 17, 2024 | 8-K Item 2.02 (results) | $6.19 |
| Feb 24, 2022 | 8-K Item 2.02 (results) | — |
| Oct 15, 2021 | 8-K Item 2.02 (results) | — |
| Jul 19, 2021 | 8-K Item 2.02 (results) | — |
| Apr 16, 2021 | 8-K Item 2.02 (results) | — |
| Feb 25, 2021 | 8-K Item 2.02 (results) | — |
| Oct 19, 2020 | 8-K Item 2.02 (results) | — |
| Jul 13, 2020 | 8-K Item 2.02 (results) | — |
| May 6, 2020 | 8-K Item 2.02 (results) | — |
| Mar 2, 2020 | 8-K Item 2.02 (results) | — |
| Oct 17, 2019 | 8-K Item 2.02 (results) | — |
| Jul 25, 2019 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Misc Health & Allied Services, NEC
Davita (DVA)Sotera Health (SHC)Fresenius Medical Care AG (FMS)Progyny (PGNY)agilon health (AGL)Viemed Healthcare (VMD)NewGenIvf (NIVF)Park Dental Partners (PARK)Mangoceuticals (MGRX)BioRestorative Therapies (BRTX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CCEL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.